> ## Content Index
> Fetch the complete content index at: https://www.fdaweb.com/llms.txt
> Use this file to discover other available public pages before exploring further.

# Medtronic’s Hemostasis Agent Cleared for Upper GI
- URL: https://www.fdaweb.com/medtronics-hemostasis-agent-cleared-for-upper-gi/
- Published: 2022-09-29T12:00:00.000Z
- Updated: 2026-09-14T18:01:11.000Z
- Author: David McFarland
- Tags: Devices, #legacy-id-D5152861

FDA has cleared a Medtronic 510(k) for its Nexpowder endoscopic hemostasis system. The device uses a noncontact, nonthermal hemostatic powder, which is sprayed through a catheter that has a proprietary powder coating to minimize clogging and provide improved visibility and control for treating upper gastrointestinal nonvariceal bleeding, according to the company.

“Once sprayed, Nexpowder immediately forms a muco-adhesive and durable gel upon contact, with or without blood, which degrades in one-to-three days,” Medtronic says. “The spray adheres to the tissue with double the adhesive force of other commercially available products, resulting in a durable hemostatic effect.”